MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Australian Patent Approval announced for SULIDIN LPS (Topical Nimesulide Gel) formulation.

Release issued 6th June 2003

Australian Patent approval No: 756007 dated 12.08.1999 has just been announced for Sulidin LPS (Topical Nimesulide Gel).

Embil will continue to obtain Patent approvals in key markets worldwide, in order to better position itself in the manufacturing and distribution of topical nimesulide formulations on a worldwide basis.

Company details

If you want to find out more about the company visit Embil Pharmaceutical Co. Ltd. profile.

Latest Embil Pharmaceutical Co. Ltd. press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us